• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.40 0.01(0.72%) Dec 24, 1:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingOct 31, 2014Jul 31, 2014Apr 30, 2014Jan 31, 2014
    Total Revenue 6,300   5,496   6,474   3,885  
    Cost of Revenue4,139  3,583  3,829  2,416  
    Gross Profit 2,161   1,913   2,645   1,469  
    Operating Expenses
    Research Development10,003  10,201  8,813  6,649  
    Selling General and Administrative4,295  4,883  4,361  4,563  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (12,137) (13,171) (10,529) (9,743)
    Income from Continuing Operations
    Total Other Income/Expenses Net37  42  281  23  
    Earnings Before Interest And Taxes(12,100)(13,129)(10,248)(9,720)
    Interest Expense -   -   -  4  
    Income Before Tax(12,100)(13,129)(10,248)(9,724)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(12,100)(13,129)(10,248)(9,724)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (12,100) (13,129) (10,248) (9,724)
    Preferred Stock And Other Adjustments(774)(1,028)(401) -  
    Net Income Applicable To Common Shares (12,874) (14,157) (10,649) (9,724)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.